While the role of myosin regulatory light polypeptide 9 (MYL9) remains poorly documented in terms of its functional association in human cancers including colon carcinoma, a recent report by Yan et al., suggest lower expressions of MYL9 was associated with lower median survival rates in colon cancer patients [63]. The gene discussed is MYL9; the disease is malignant colon neoplasm.